Back to results
US 2008/0176818 A1Published application
Sulfoglycolipid Antigens, Their Extraction From Mycobacterium Tuberculosis, and Their Use Against Tuberculosis
AssigneeCentre National De La Recherche Scientifique
InventorsGermain Puzo, Martine Gilleron, Steffen Stenger, Gennaro De Libero
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of the following general formula: (I) wherein R1 and R2 are fatty acyl groups, a process to extract them from Mycobacterium tuberculosis, and their use in the treatment or the prophylaxis of tuberculosis.
Claims25
1-23. (canceled)
A compound of the following general formula (I):
- wherein R1 and R2 are fatty acyl groups.
A process for generating T cell clones, characterized in that said process comprises the following stages:
- incubating antigen presenting cells (APCs), with a Mycobacterium tuberculosis envelope preparation substantially devoid of proteins, to obtain non-protein envelope antigen loaded APCs,
- contacting peripheral blood mononuclear cells with the envelope antigen loaded APCs to obtain proliferating T cells,
- cloning proliferating T cells by limiting dilution and selecting the clones releasing a molecule selected from the group comprising IFN-γ, TNF-α, granulysin or IL-4 when contacted by envelope antigen loaded APCs to obtain T cell clones.
Dependencies are inferred from the claim text.